Employment News
ZymoGenetics to Abandon Cancer Research, Cut 160 Jobs
By Erik Even | Dated: 04-30-2009
Seattle, Washington’s ZymoGenetics will cut 161 employees and discontinue research on cancer treatments.The firm will continue to market its only approved product, the blood-clotting compound Recothrom Thrombin, and will narrow its research focus to immunology.
ZymoGenetics said the terminated employees will get severance benefits.
ZymoGenetics is a biotechnology and pharmaceutical firm involved in the development of therapeutic proteins. The company was founded in 1981 by Earl W. Davie and Benjamin D. Hall of the University of Washington, and 1993 Nobel Laureate in Chemistry Michael Smith of the University of British Columbia.
Career Connect (From our other career blogs):
- Employment News (Sponsored by EmploymentSpectator)
- Following Your Passion-Literally! (Sponsored by iamnotastalker.com)
- Job Search Advice from the CEO of TravelingCrossing (Sponsored by aharrisonbarnes.com)
- Layoff News (Sponsored by LayOffWatch)
Testimonial of the Week
I like the volume of jobs on EmploymentCrossing. The quality of jobs is also good. Plus, they get refreshed very often. Great work!
- Roberto D Seattle, WA
Sign Up now
Only TravelingCrossing consolidates every job it can find in the domain and puts all of the job listings it locates in one place.
- We have more jobs than any other job board.
- We list jobs you will not find elsewhere that are hidden in small regional publications and employer websites
- We collect jobs from more than 4,429,376 websites and post them on our site.
- We are private, and therefore far fewer people are applying for the jobs on our site than are applying for those on public job boards.
